Anti-Hu antibody titre and brain metastases before and after treatment for small cell lung cancer

Verschuuren, Jan J.; Perquin, Mark; Velde, Guul ten; De Baets, Marc; van Breda Vriesman, Peter; Twijnstra, Albert
September 1999
Journal of Neurology, Neurosurgery & Psychiatry;Sep1999, p353
Academic Journal
No abstract available.


Related Articles

  • POC19 Anti-Hu paraneoplastic sensory neuronopathy with underlying squamous cell carcinoma of the lung. P Gozzard // Journal of Neurology, Neurosurgery & Psychiatry;Nov2010, Vol. 81 Issue 11, pe39 

    Type 1 anti-neuronal nuclear antibody (ANNA-1), also known as anti-Hu, recognises a family of RNA binding proteins, expressed in neuronal nuclei throughout the human neuraxis. Its presence usually reflects immunity against neuroendocrine tumours, in particular small-cell-lung cancer (SCLC). When...

  • Anti-Hu antibodies may indicate a positive response to chemotherapy in paraneoplastic syndrome secondary to small cell lung cancer. Douglas, Claire A.; Ellershaw, John // Palliative Medicine;Nov2003, Vol. 17 Issue 7, p638 

    Paraneoplastic encephalomyelitis (PEM) is a form of neurological dysfunction caused by the remote effect of small cell lung cancer (SCLC) on the brain. In certain cases it is associated with the presence of Anti-Hu antibodies. Up to 65% of patients with SCLC and PEM, who have Anti-Hu antibodies...

  • Bevacizumab.  // Reactions Weekly;Mar2015, Vol. 1543 Issue 1, p48 

    The article discusses a retrospective study which examined patients who developed various toxicities after receiving bevacizumab treatment for non-small cell lung cancer (NSCLC), brain metastases, and other diseases.

  • Successful Treatment with Methylnaltrexone and IVIG for Paraneoplastic Syndrome- Associated Intestinal Pseudo-Obstruction. Cheng Zhang; Patel, Niravkumar J.; Jacobs, W. Carl; Ullman, Sonal; Berzin, Tyler M.; Chuttani, Ram; Lembo, Anthony J.; Wolf, Jacqueline L. // Gastroenterology & Hepatology;Jan2013, Vol. 9 Issue 1, p48 

    Paraneoplastic syndromes are systemic disorders that are associated with malignancy but are not directly due to the local effects of a tumor mass or its metastases. These syndromes are most commonly associated with small cell lung cancer or thymoma. Paraneoplastic syndromes frequently present...

  • Gefitinib.  // Reactions Weekly;6/12/2010, Issue 1305, p17 

    The article describes two cases of haemorrhage of brain metastases while receiving oral gefitinib treatment for metastatic non-small cell lung cancer.

  • Rare Association of Anti-Hu Antibody Positive Paraneoplastic Neurological Syndrome and Transitional Cell Bladder Carcinoma. Lukacs, S.; Szabo, N.; Woodhams, S. // Case Reports in Urology;2012, p1 

    Introduction. Paraneoplastic encephalomyelitis (PEM) and subacute sensory neuronopathy (SSN) are remote effects of cancer, usually associated with small-cell lung carcinoma and positive anti-Hu antibody. We describe the rare association of bladder transitional cell carcinoma (TCC) with anti-Hu...

  • Systemic Chemotherapy for Progression of Brain Metastases in Extensive-Stage Small Cell Lung Cancer. Abdel Karim, Nagla; Bhatt, Ananta; Chiec, Lauren; Curry, Richard // Case Reports in Oncological Medicine;8/28/2015, Vol. 2015, p1 

    Lung cancer is the most common cause of cancer related mortality in men and women. Approximately 15% of lung cancers are small cell type. Chemotherapy and radiation are the mainstay treatments. Currently, the standard chemotherapy regimen includes platinum/etoposide. For extensive small cell...

  • Skin metastases from lung cancer: a case report. Pajaziti, Laura; Hapçiu, Syzana Rexhepi; Dobruna, Shkendije; Hoxha, Naim; Kurshumliu, Fisnik; Pajaziti, Artina // BMC Research Notes;2015, Vol. 8 Issue 1, p1 

    Background: Lung cancer is one of the most frequent malignancies, with high mortality rates. It can metastasize in almost all organs, but more often invades hilar nodes, liver, adrenal glands, bones and brain. There are various data on the incidence of lung cancer metastases in the skin. In...

  • Treatment of Brain Metastasis from Lung Cancer. Chi, Alexander; Komaki, Ritsuko // Cancers;2010, Vol. 2 Issue 4, p2100 

    Brain metastases are not only the most common intracranial neoplasm in adults but also very prevalent in patients with lung cancer. Patients have been grouped into different classes based on the presence of prognostic factors such as control of the primary tumor, functional performance status,...

  • Therapeutic strategy for non-small-cell lung cancer patients with brain metastases (Review). YOUNG HAK KIM; HIROKI NAGAI; HIROAKI OZASA; YUICHI SAKAMORI; MICHIAKI MISHIMA // Biomedical Reports;2013, Vol. 1 Issue 5, p691 

    Brain metastases are frequently encountered in patients with non-small-cell lung cancer (NSCLC) and are a significant cause of morbidity and mortality. Chemotherapy has been deemed ineffective under the hypothesis that the blood-brain barrier (BBB) limits the delivery of chemotherapeutic agents...


Read the Article


Sign out of this library

Other Topics